Literature DB >> 24148305

The potential role of CAMSAP1L1 in symptomatic epilepsy.

Shuai Zhang1, Patrick Kwan, Larry Baum.   

Abstract

In a recent genome-wide association study (GWAS) of symptomatic epilepsy in the Chinese population, the most significant single nucleotide polymorphism (SNP) allele was rs2292096 [G] (P=1.0×10(-8), odds ratio [OR]=0.63), in the CAMSAP1L1 gene (also known as CAMSAP2). Here, we report that rs2292096 genotypes tended to associate with expression of CAMSAP1L1 RNA in the temporal lobe (p=0.054) and hippocampus (p=0.20) of epilepsy surgery patients, with expression tending to increase with the G allele. CAMSAP1L1 and β-tubulin double immunofluorescence exhibited partial overlap. CAMSAP1L1 siRNA transfection of human SH-SY5Y neuroblastoma cells treated with or without retinoic acid reduced the CAMSAP1L1 protein level nearly 60% and stimulated neurite outgrowth, as measured by total length, number of processes and number of branches. Therefore, the rs2292096 G allele of CAMSAP1L1, which was associated with reduced risk of symptomatic epilepsy, tended to associate with increased expression of CAMSAP1L1, which represses neurite outgrowth. Greater neurite growth in response to brain insults might increase formation of ectopic neural circuits and thus the risk of epileptogenesis.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  CAMSAP1L1; CAMSAP2; Epileptogenesis; Neurites; Symptomatic epilepsy

Mesh:

Substances:

Year:  2013        PMID: 24148305     DOI: 10.1016/j.neulet.2013.10.020

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  1 in total

1.  Cell-Based Systems Biology Analysis of Human AS03-Adjuvanted H5N1 Avian Influenza Vaccine Responses: A Phase I Randomized Controlled Trial.

Authors:  Leigh M Howard; Kristen L Hoek; Johannes B Goll; Parimal Samir; Allison Galassie; Tara M Allos; Xinnan Niu; Laura E Gordy; C Buddy Creech; Nripesh Prasad; Travis L Jensen; Heather Hill; Shawn E Levy; Sebastian Joyce; Andrew J Link; Kathryn M Edwards
Journal:  PLoS One       Date:  2017-01-18       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.